Description: Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers small-volume injections, freeze-dried powder injections, powder injections, large-volume injections, active pharmaceutical ingredient, etc. for various therapeutic fields, including anti-infective, digestive system, blood system, nervous system, parenteral nutrition, antibiotics, first aid, anesthetics, and tumor; and tablets, capsules, granules, and ointments in the fields of cardiovascular, anti-infection, digestive system, CNS system, diabetes, and hepatic diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.
Home Page: www.haisco.com
No.17, Sanxiang Avenue
Shannan,
China
Phone:
86 89 3783 4870
Officers
| Name | Title |
|---|---|
| Ms. Xiu Lian Fan | MD & Director |
| Ms. Peng Duan | Financial Director |
| Mr. Wei Zhang | Deputy GM & Director |
| Mr. Pangke Yan | Deputy GM & Director |
| Mr. Meng Wang | Deputy GM & Board Sec. |
| Ms. Han Bing Liu | HR Mang. |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 149.1875 |
| Price-to-Book MRQ: | 7.922 |
| Price-to-Sales TTM: | 7.565 |
| IPO Date: | 2011-12-29 |
| Fiscal Year End: | December |
| Full Time Employees: | 4247 |